
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

Collaboration to improve process analytical technologies and AAV manufacturing for gene therapies

Expert interview on the use of AI in the ATMP industry

Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim
Rentschler Biopharma
Flexibility
We believe that revolutionary ideas come to life when they have the space to develop.
Clients
The unique feature of our client dialogue is actually quite simple: We are listening.
Solutions
Our secret: We find solutions where others do not even look.
Performance
Our track record: Security for our clients. Guidepost for our future.
Our Services
As a leading CDMO, we develop and manufacture biopharmaceuticals and support you with the creation of approval documents at an international level. We are a specialist for mammalian expression. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler Biopharma’s high quality standards. With our full-service offering, we are your partner of choice.